Back to Search Start Over

Sex-specific cytotoxicity of ostarine in cardiomyocytes.

Authors :
Leciejewska N
Pruszyńska-Oszmałek E
Nogowski L
Sassek M
Strowski MZ
Kołodziejski PA
Source :
Molecular and cellular endocrinology [Mol Cell Endocrinol] 2023 Nov 01; Vol. 577, pp. 112037. Date of Electronic Publication: 2023 Aug 03.
Publication Year :
2023

Abstract

Ostarine is the most popular compound in the selective androgen receptor modulator group (SARMs). Ostarine is used as a physical performance-enhancing agent. The abuse of this agent in higher doses may lead to severe side effects. Here, we evaluate the effects of ostarine on the heart. We utilized a cardiomyocyte H9C2 cell line, isolated primary female and male cardiac fibroblast cells, as well as hearts obtained from rats. Ostarine increased the accumulation of two fibrosis protein markers, αSMA and fibronectin (p < 00.1) in male, but not in female fibroblast cells. Ostarine increased the expression of the cardiomyopathy marker βMhc in the H9C2 cell line (p < 0.05) and in the heart in rats (p < 0.01). The unfavorable changes were observed at high ostarine doses. Moreover, a decrease in viability and an increase in cytotoxicity marker LDH were observed already at lowest dose (1 nmoL/l). Taken together, our results suggest that ostarine is cardiotoxic which may be more relevant in males than in females.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-8057
Volume :
577
Database :
MEDLINE
Journal :
Molecular and cellular endocrinology
Publication Type :
Academic Journal
Accession number :
37543162
Full Text :
https://doi.org/10.1016/j.mce.2023.112037